
Laura K. Tso
Examiner (ID: 1977, Phone: (571)272-2385 , Office: P/2875 )
| Most Active Art Unit | 2875 |
| Art Unit(s) | 2875, 3303, 3302, 2109, 2831, 2103 |
| Total Applications | 3051 |
| Issued Applications | 2669 |
| Pending Applications | 113 |
| Abandoned Applications | 284 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6343825
[patent_doc_number] => 20020035069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-21
[patent_title] => 'Use of ribose supplementation for increasing muscle mass and decreasing body fat in humans'
[patent_app_type] => new
[patent_app_number] => 09/766858
[patent_app_country] => US
[patent_app_date] => 2001-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2746
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20020035069.pdf
[firstpage_image] =>[orig_patent_app_number] => 09766858
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/766858 | Use of ribose supplementation for increasing muscle mass and decreasing body fat in humans | Jan 18, 2001 | Issued |
Array
(
[id] => 7118523
[patent_doc_number] => 20010001789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-05-24
[patent_title] => 'Conditioning solutions for hard contact lens care'
[patent_app_type] => new-utility
[patent_app_number] => 09/765234
[patent_app_country] => US
[patent_app_date] => 2001-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5001
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0001/20010001789.pdf
[firstpage_image] =>[orig_patent_app_number] => 09765234
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/765234 | Conditioning solutions for contact lens care | Jan 17, 2001 | Issued |
| 09/674673 | Novel anthracycline derivatives and their preparation | Jan 15, 2001 | Abandoned |
Array
(
[id] => 742030
[patent_doc_number] => 07030237
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-18
[patent_title] => 'Method and equipment for continuous and selective inclusion separation'
[patent_app_type] => utility
[patent_app_number] => 10/009627
[patent_app_country] => US
[patent_app_date] => 2000-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 10729
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/030/07030237.pdf
[firstpage_image] =>[orig_patent_app_number] => 10009627
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/009627 | Method and equipment for continuous and selective inclusion separation | Dec 20, 2000 | Issued |
Array
(
[id] => 6678885
[patent_doc_number] => 20030229026
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-11
[patent_title] => 'Agents and methods for the treatment of proliferative diseases'
[patent_app_type] => new
[patent_app_number] => 10/130493
[patent_app_country] => US
[patent_app_date] => 2002-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53195
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20030229026.pdf
[firstpage_image] =>[orig_patent_app_number] => 10130493
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/130493 | Agents and methods for the treatment of proliferative diseases | Dec 17, 2000 | Issued |
Array
(
[id] => 1393223
[patent_doc_number] => 06545006
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-08
[patent_title] => 'Process for obtaining L-dihydroorotic acid and use thereof'
[patent_app_type] => B1
[patent_app_number] => 09/581142
[patent_app_country] => US
[patent_app_date] => 2000-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7546
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/545/06545006.pdf
[firstpage_image] =>[orig_patent_app_number] => 09581142
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/581142 | Process for obtaining L-dihydroorotic acid and use thereof | Dec 10, 2000 | Issued |
Array
(
[id] => 1560404
[patent_doc_number] => 06436980
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-20
[patent_title] => 'Peptidomimetic efflux pump inhibitors'
[patent_app_type] => B1
[patent_app_number] => 09/724818
[patent_app_country] => US
[patent_app_date] => 2000-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26451
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 287
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/436/06436980.pdf
[firstpage_image] =>[orig_patent_app_number] => 09724818
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/724818 | Peptidomimetic efflux pump inhibitors | Nov 27, 2000 | Issued |
Array
(
[id] => 1589902
[patent_doc_number] => 06482939
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-19
[patent_title] => 'Form vi 5,6-dichloro-2-(isopropylamino)-1-(-l-ribofuranosyl)-1h-bezimimidazole'
[patent_app_type] => B1
[patent_app_number] => 09/647868
[patent_app_country] => US
[patent_app_date] => 2000-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9741
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/482/06482939.pdf
[firstpage_image] =>[orig_patent_app_number] => 09647868
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/647868 | Form vi 5,6-dichloro-2-(isopropylamino)-1-(-l-ribofuranosyl)-1h-bezimimidazole | Nov 16, 2000 | Issued |
Array
(
[id] => 7640022
[patent_doc_number] => 06395893
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-28
[patent_title] => 'Crystallization of lactitol, crystalline lactitol product and use thereof'
[patent_app_type] => B1
[patent_app_number] => 09/646411
[patent_app_country] => US
[patent_app_date] => 2000-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6485
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/395/06395893.pdf
[firstpage_image] =>[orig_patent_app_number] => 09646411
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/646411 | Crystallization of lactitol, crystalline lactitol product and use thereof | Nov 8, 2000 | Issued |
Array
(
[id] => 1440609
[patent_doc_number] => 06495678
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-17
[patent_title] => 'Immunosuppressant containing glucopyranose derivative as active ingredient'
[patent_app_type] => B1
[patent_app_number] => 09/674808
[patent_app_country] => US
[patent_app_date] => 2000-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5887
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 257
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/495/06495678.pdf
[firstpage_image] =>[orig_patent_app_number] => 09674808
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/674808 | Immunosuppressant containing glucopyranose derivative as active ingredient | Nov 5, 2000 | Issued |
Array
(
[id] => 1377711
[patent_doc_number] => 06559131
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-06
[patent_title] => 'Use of fucane for regulating the reconstruction of connective tissue'
[patent_app_type] => B1
[patent_app_number] => 09/581810
[patent_app_country] => US
[patent_app_date] => 2000-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3868
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/559/06559131.pdf
[firstpage_image] =>[orig_patent_app_number] => 09581810
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/581810 | Use of fucane for regulating the reconstruction of connective tissue | Nov 5, 2000 | Issued |
Array
(
[id] => 1545750
[patent_doc_number] => 06444654
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-03
[patent_title] => 'Isolated asgal lipopolysaccharides and use of same to inhibit innate immune response'
[patent_app_type] => B1
[patent_app_number] => 09/703258
[patent_app_country] => US
[patent_app_date] => 2000-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 19
[patent_no_of_words] => 7809
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/444/06444654.pdf
[firstpage_image] =>[orig_patent_app_number] => 09703258
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/703258 | Isolated asgal lipopolysaccharides and use of same to inhibit innate immune response | Oct 30, 2000 | Issued |
Array
(
[id] => 1312823
[patent_doc_number] => 06613897
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-02
[patent_title] => 'Compounds having glucuronic acid derivatives and glucosamine derivative in the structure, process for producing the same and utilization thereof'
[patent_app_type] => B1
[patent_app_number] => 09/674252
[patent_app_country] => US
[patent_app_date] => 2000-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13981
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 444
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/613/06613897.pdf
[firstpage_image] =>[orig_patent_app_number] => 09674252
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/674252 | Compounds having glucuronic acid derivatives and glucosamine derivative in the structure, process for producing the same and utilization thereof | Oct 29, 2000 | Issued |
Array
(
[id] => 1491229
[patent_doc_number] => 06417346
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-09
[patent_title] => 'Process for preparing a noncrystallizable polyol syrup'
[patent_app_type] => B1
[patent_app_number] => 09/693177
[patent_app_country] => US
[patent_app_date] => 2000-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4184
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/417/06417346.pdf
[firstpage_image] =>[orig_patent_app_number] => 09693177
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/693177 | Process for preparing a noncrystallizable polyol syrup | Oct 19, 2000 | Issued |
Array
(
[id] => 1339009
[patent_doc_number] => 06593469
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-15
[patent_title] => 'Compositions including reduced malto-oligosaccharide preserving agents'
[patent_app_type] => B1
[patent_app_number] => 09/693496
[patent_app_country] => US
[patent_app_date] => 2000-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7953
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/593/06593469.pdf
[firstpage_image] =>[orig_patent_app_number] => 09693496
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/693496 | Compositions including reduced malto-oligosaccharide preserving agents | Oct 19, 2000 | Issued |
Array
(
[id] => 1403464
[patent_doc_number] => 06528042
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-04
[patent_title] => 'Compositions of flavonoids for use as cytoprotectants and methods of making and using them'
[patent_app_type] => B1
[patent_app_number] => 09/684607
[patent_app_country] => US
[patent_app_date] => 2000-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27895
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/528/06528042.pdf
[firstpage_image] =>[orig_patent_app_number] => 09684607
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/684607 | Compositions of flavonoids for use as cytoprotectants and methods of making and using them | Oct 5, 2000 | Issued |
Array
(
[id] => 1521726
[patent_doc_number] => 06414126
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-02
[patent_title] => 'C-aryl glucoside SGLT2 inhibitors and method'
[patent_app_type] => B1
[patent_app_number] => 09/679027
[patent_app_country] => US
[patent_app_date] => 2000-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22150
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/414/06414126.pdf
[firstpage_image] =>[orig_patent_app_number] => 09679027
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/679027 | C-aryl glucoside SGLT2 inhibitors and method | Oct 3, 2000 | Issued |
Array
(
[id] => 4272574
[patent_doc_number] => 06323186
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-27
[patent_title] => 'Phosphate-bound polyazaindacene derivatives of nucleotides'
[patent_app_type] => 1
[patent_app_number] => 9/664315
[patent_app_country] => US
[patent_app_date] => 2000-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 5936
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/323/06323186.pdf
[firstpage_image] =>[orig_patent_app_number] => 664315
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/664315 | Phosphate-bound polyazaindacene derivatives of nucleotides | Sep 17, 2000 | Issued |
Array
(
[id] => 4370967
[patent_doc_number] => 06274761
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-14
[patent_title] => 'Process for the preparation of sulphonated distyryl-biphenyl compounds'
[patent_app_type] => 1
[patent_app_number] => 9/646397
[patent_app_country] => US
[patent_app_date] => 2000-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5515
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/274/06274761.pdf
[firstpage_image] =>[orig_patent_app_number] => 646397
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/646397 | Process for the preparation of sulphonated distyryl-biphenyl compounds | Sep 14, 2000 | Issued |
Array
(
[id] => 1470157
[patent_doc_number] => 06407070
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-18
[patent_title] => 'Solid pharmaceutical composition for dialysate containing sodium bicarbonate and a process for producing the same'
[patent_app_type] => B1
[patent_app_number] => 09/655450
[patent_app_country] => US
[patent_app_date] => 2000-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4949
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/407/06407070.pdf
[firstpage_image] =>[orig_patent_app_number] => 09655450
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/655450 | Solid pharmaceutical composition for dialysate containing sodium bicarbonate and a process for producing the same | Sep 4, 2000 | Issued |